Hour24 News
Sophisticated and simple
-
Oncology /Stereotactic body radiation therapy and the TORPEDO trial: A new approach for inoperable pancreatic cancer
Overview: SBRT as a potential option for inoperable PDAC Pancreatic ductal adenocarcinoma (PDAC) remains one of the most challenging cancers to treat, especially when surgical…
-
Overview: A cytokine-driven route to osimertinib resistance in EGFR-mutant NSCLC Osimertinib has transformed treatment for patients with EGFR-mutant non-small cell lung cancer (NSCLC) but resistance…
-
Breakthrough Immunotherapy Helps Patients With Locally Advanced Head and Neck Cancer A pivotal advance in the treatment of locally advanced head and neck cancer centers…
-
New hope for locally advanced head and neck cancer: pembrolizumab Locally advanced tumors in the head and neck region pose a formidable challenge. They are…
-
The Breakthrough: A New Immunotherapy Redefines Outcomes in Locally Advanced Head and Neck Cancer Locally advanced head and neck cancer poses a formidable challenge. In…
-
Revolutionizing NPC management with radiomics Nasopharyngeal carcinoma (NPC) remains challenging, with many patients presenting at locally advanced stages. Immunotherapy, including PD-1 blockade, has improved outcomes…
-
Groundbreaking Insight: Radiomics Elevates NPC Immunotherapy Prediction Nasopharyngeal carcinoma (NPC) remains a highly aggressive cancer, with most patients presenting at locally advanced stages. While immune…
-
Overview New data presented at the American Society for Radiation Oncology (ASTRO) meeting suggest that adding the radiopharmaceutical Lu-177 PNT2002 to stereotactic body radiation therapy…
-
Breakthrough at a Glance In a landmark development from the United States, researchers have described an experimental immunotherapy that can attack several cancer types while…
-
What the LUNAR trial tested SAN FRANCISCO, September 28, 2025 — A new phase II clinical trial, called LUNAR, shows that adding a radiopharmaceutical drug…
